Konstantinos Xynos, Chief Medical Officer at Replimune Group, Inc. (REPL), sold 31,762 shares at $7.50 ($238K) on 2024-06-07, disclosed to the SEC on 2024-06-10.
Scheduled sale ($238k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.50 | 15,881 | $119K | 50.0% |
| 2 | $7.50 | 15,881 | $119K | 50.0% |
| Total | $7.50 avg | 31,762 | $238K | 100% |
| Filing → |
| REPL | SELL | 2025-11-19 | $132K | — | Filing → |
| REPL | SELL | 2025-05-22 | $128K | — | Filing → |
| REPL | SELL | 2024-11-20 | $156K | — | Filing → |